XML 63 R51.htm IDEA: XBRL DOCUMENT v3.22.1
Segment Reporting - Revenues and Operating Income by Reportable Segment (Details)
$ in Millions
 1 Months Ended 3 Months Ended
Mar. 31, 2022
USD ($)
Mar. 31, 2022
USD ($)
segment
Mar. 31, 2021
USD ($)
Segment Reporting [Abstract]      
Number of operating segments | segment   2  
Segment Reporting Information [Line Items]      
Revenues   $ 596.2 $ 512.4
Adjusted EBITDA   77.1 72.9
Reconciliation of Adjusted EBITDA:      
Income before income taxes   44.1 11.0
Net income attributable to non-controlling interests   (30.6) (31.8)
Depreciation and amortization   27.4 25.7
Interest expense, net   56.3 53.3
Equity-based compensation expense   3.7 5.2
Transaction, integration and acquisition costs   7.1 9.4
Gain on disposals and deconsolidations, net   (0.1) (0.9)
(Gain) loss on litigation settlement and other litigation costs   (30.8) 1.0
Adjusted EBITDA   77.1 72.9
Transaction and integration costs   7.1 5.3
Start-up costs     4.1
Other litigation costs   2.0 1.0
Litigation settlement $ (32.8) (32.8) 0.0
Operating Segments | Surgical Facility Services      
Segment Reporting Information [Line Items]      
Revenues   578.8 495.8
Adjusted EBITDA   101.0 95.0
Reconciliation of Adjusted EBITDA:      
Adjusted EBITDA   101.0 95.0
Operating Segments | Ancillary Services      
Segment Reporting Information [Line Items]      
Revenues   17.4 16.6
Adjusted EBITDA   0.1 (0.9)
Reconciliation of Adjusted EBITDA:      
Adjusted EBITDA   0.1 (0.9)
All other      
Segment Reporting Information [Line Items]      
Adjusted EBITDA   (24.0) (21.2)
Reconciliation of Adjusted EBITDA:      
Adjusted EBITDA   $ (24.0) $ (21.2)